Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan [Phase 2, Phase 3]
A clinical trial in Amman, Jordan is assessing the effect of probiotic supplementation on the immune system in patients with Ulcerative Coli…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ENhanced Recovery in CHildren Undergoing Surgery [Phase 3]
A Phase 3 clinical trial assessing Enhanced Recovery in children undergoing surgery for inflammatory bowel disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Digital Behavioral Interventions in Inflammatory Bowel Disease [NA]
A completed clinical trial conducted at Montefiore Medical Center evaluated digital behavioral interventions for patients with Crohn's disea…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients [Phase 2]
Phase 2 clinical trial evaluating FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study) [NA]
Clinical trial update for the OPTIMISE study evaluating whether timely therapy adjustments guided by self-monitoring improve outcomes in mil…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission [NA]
A completed clinical trial from Benha University explored whether combining anti-parasitic therapy with immunomodulatory treatment could ind…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients
Results from a Korea post-marketing surveillance study of Xeljanz (tofacitinib) in Ulcerative Colitis patients have completed and results we…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: A Study on How Vedolizumab is Given and the Outcomes for Adults With Inflammatory Bowel Disease (VARIETY-Belgium)
A completed study assessing how vedolizumab is administered and the outcomes in adults with inflammatory bowel disease (VARIETY-Belgium).
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC [Phase 3]
Phase 3 clinical trial evaluating pharmacokinetics, efficacy and safety of subcutaneous CT-P13 as induction therapy in adults with active Cr…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis [Phase 4]
Phase 4 clinical trial comparing two golimumab dosing regimens for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: A Study of Vedolizumab in Adults in Real-World Practice
This real-world study of Vedolizumab in adults with ulcerative colitis or Crohn's disease has completed. It evaluated treatment outcomes in …
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 study evaluating the safety, efficacy, and biomarker response of BMS-986165 in adults with moderate to severe ulcerative colitis has…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis [Phase 2]
This is a Phase 2 long-term treatment trial of BI 655130 for adults with moderate-to-severe ulcerative colitis that has completed. Results w…
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease [Phase 1]
A Phase 1 study assessing whether intravenous risankizumab alters the pharmacokinetics of cytochrome P450 substrates in adults with moderate…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) [Phase 2]
Phase 2 safety and efficacy study of Tulisokibart (MK-7240/PRA023) in moderately to severely active ulcerative colitis completed, with resul…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: PRognOstiC valuE of rEd Density in Ulcerative Colitis
This update summarizes a completed clinical trial evaluating whether red density can prognosticate outcomes in ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis
The Belgian SMART trial evaluating golimumab for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny [NA]
A completed KU Leuven study evaluated whether home-based fecal calprotectin measurements can predict the induction outcome of adalimumab in …
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) [Phase 3]
Safety extension results from a Phase 3 trial of ontamalimab in moderate to severe Crohn's disease or ulcerative colitis have been completed…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)
Completed comparative effectiveness trial comparing biologics and small-molecule therapies for Crohn's disease and ulcerative colitis, with …
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission [NA]
This update reports a terminated clinical trial comparing trough-level–based spacing to clinically based spacing of infliximab infusions in …
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Artificial Intelligence and Dysplasia Detection in Ulcerative Colitis (CUDISIA Study) [NA]
A completed clinical trial (CUDISIA) evaluating artificial intelligence–assisted detection of dysplasia in patients with ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2024-05-30Clinical Trial Update: A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
A completed real-world observational study evaluating vedolizumab and anti-TNF therapies in patients with ulcerative colitis or Crohn's dise…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: The PRognostic Effect of Environmental Factors in Crohn's and Colitis
This clinical trial evaluated the prognostic impact of environmental factors on inflammatory bowel diseases, specifically Crohn's disease an…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Boosting Biologics in UC [NA]
Clinical trial at Oslo University Hospital has completed a study investigating biologics for Ulcerative Colitis, part of inflammatory bowel …